Exempts the following from the definition of "compounding" for purposes of chapter 18.64 RCW: Mixing, reconstitution, or other acts that are performed in accordance with directions contained in approved labeling provided by the product's manufacturer and other manufacturer directions consistent with that labeling.

Requires medicinal preparations that are compounded for patient administration or distribution to a licensed practitioner for patient use or administration to meet the standards of the official United States pharmacopeia as it applies to nonsterile and sterile administered preparations.

Requires the pharmacy quality assurance commission to adopt rules identifying which chapters or provisions of the official United States pharmacopeia are applicable to nonsterile and sterile products and preparations compounded for patient administration or distribution to a licensed practitioner for patient use or administration.